|Articles|June 1, 1996

June 1996
Volume 2
Issue 6

Consequences of Prior Authorization Programs -- A Case Example: DDAVP in Pediatric Nocturnal Enuresis

Author(s)Charles A. Carter, PharmD, MBA, Rowe B. Brookfield, PharmD

Download PDF: Consequences of Prior Authorization Programs -- A Case Example: DDAVP in Pediatric Nocturnal Enuresis

Articles in this issue

about 30 years ago

Article

Chest Pain

about 30 years ago

Article

The Corporatization of American Medicine: The Impact of Managed Care on the Doctor-Patient Relationship

about 30 years ago

Article

Correspondence regarding, "Diagnosis and Eradication of Helicobacter pylori in the Management of Peptic Ulcer Disease: A Decision Analysis Model"

about 30 years ago

Article

Correspondence regarding Computed Tomography Scans

about 30 years ago

Article

Outcome and Cost Analysis of Preterm Premature Rupture of Membranes in an Outpatient Setting

about 30 years ago

Article

An Alternative Framework for Evaluating the Efficiency of Managed Care

about 30 years ago

Article

Management of Dyspepsia: A Decision Analysis Model

about 30 years ago

Article

The Effectiveness of an Influenza Vaccination Program in an HMO Setting

about 30 years ago

Article

The Emerging Use of Economic Models in the Life-Cycle of Pharmaceutical Products

about 30 years ago

Article

Primary Care Physicians' Attitudes Toward Capitated Care: A Potential Quality of Care Measure

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Consequences of Prior Authorization Programs -- A Case Example: DDAVP in Pediatric Nocturnal Enuresis

Articles in this issue

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

Trending on AJMC

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology

Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD

SENTRY Trial Shows Survival, Spleen Benefits in Myelofibrosis: Claire Harrison, MD